标题
Pharmacogenetics of Response to Antipsychotics in Patients with Schizophrenia
作者
关键词
-
出版物
CNS DRUGS
Volume 25, Issue 11, Pages 933-969
出版商
Springer Nature
发表日期
2011-11-05
DOI
10.2165/11595380-000000000-00000
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The clinical effectiveness and cost-effectiveness of testing for cytochrome P450 polymorphisms in patients with schizophrenia treated with antipsychotics: a systematic review and economic evaluation
- (2014) N Fleeman et al. HEALTH TECHNOLOGY ASSESSMENT
- The association between weight change and symptom reduction in the CATIE schizophrenia trial
- (2011) Eric Hermes et al. SCHIZOPHRENIA RESEARCH
- Genetic association between TNF-α −308 G>A polymorphism and longitudinal weight change during clozapine treatment
- (2010) Ying-Chieh Wang et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Association study of polymorphisms in Insulin Induced Gene 2 (INSIG2) with antipsychotic-induced weight gain in European and African-American schizophrenia patients
- (2010) Arun K. Tiwari et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Schizophrenia severity and clozapine treatment outcome association with oxytocinergic genes
- (2010) Renan P. Souza et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Lack of association between the −759C/T polymorphism of the 5-HT2C receptor gene and olanzapine-induced weight gain among Korean schizophrenic patients
- (2010) Y.-M. Park et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Candidate Gene Analysis Identifies a Polymorphism inHLA-DQB1Associated With Clozapine-Induced Agranulocytosis
- (2010) Maria C. Athanasiou et al. JOURNAL OF CLINICAL PSYCHIATRY
- Advanced Research on Dopamine Signaling to Develop Drugs for the Treatment of Mental Disorders: Ser311Cys Polymorphisms of the Dopamine D2–Receptor Gene and Schizophrenia
- (2010) Masanari Itokawa et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Genetic association of the GDNF alpha-receptor genes with schizophrenia and clozapine response
- (2010) Renan P. Souza et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Influence of serotonin transporter gene polymorphisms on clozapine response in Brazilian schizophrenics
- (2010) Fabiana B. Kohlrausch et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs
- (2010) D E Adkins et al. MOLECULAR PSYCHIATRY
- A Common Polymorphism in the Cannabinoid Receptor 1 (CNR1) Gene is Associated with Antipsychotic-Induced Weight Gain in Schizophrenia
- (2010) Arun K Tiwari et al. NEUROPSYCHOPHARMACOLOGY
- Genome-Wide Pharmacogenomic Study of Neurocognition As an Indicator of Antipsychotic Treatment Response in Schizophrenia
- (2010) Joseph L McClay et al. NEUROPSYCHOPHARMACOLOGY
- HTR2Cpromoter polymorphisms are associated with risperidone efficacy in Chinese female patients
- (2010) Bao-Cheng Liu et al. PHARMACOGENOMICS
- Association ofHTR2C, but notLEPorINSIG2, genes with antipsychotic-induced weight gain in a German sample
- (2010) Carolin Opgen-Rhein et al. PHARMACOGENOMICS
- Association study of polymorphisms in cholecystokinin gene and its receptors with antipsychotic induced weight gain in schizophrenia patients
- (2010) Arun K. Tiwari et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- MDR1 gene polymorphisms and response to acute risperidone treatment
- (2010) Matej Kastelic et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Association of the manganese superoxide dismutase gene Ala–9Val polymorphism with clinical phenotypes and tardive dyskinesia in schizophrenic patients
- (2010) Hong Liu et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Gender-specific prolactin response to antipsychotic treatments with risperidone and olanzapine and its relationship to drug concentrations in patients with acutely exacerbated schizophrenia
- (2010) Norio Yasui-Furukori et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Pharacogenetic effects of dopamine transporter gene polymorphisms on response to chlorpromazine and clozapine and on extrapyramidal syndrome in schizophrenia
- (2010) Mingqing Xu et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Clinical predictors of response to olanzapine or risperidone during acute episode of schizophrenia
- (2010) Georges Brousse et al. PSYCHIATRY RESEARCH
- Serotonin transporter polymorphisms and early response to antipsychotic treatment in first episode of psychosis
- (2010) Javier Vázquez-Bourgon et al. PSYCHIATRY RESEARCH
- Early response to antipsychotic therapy as a clinical marker of subsequent response in the treatment of patients with first-episode psychosis
- (2010) Virginia L. Stauffer et al. PSYCHIATRY RESEARCH
- MTHFR and risk of metabolic syndrome in patients with schizophrenia
- (2010) Ruud van Winkel et al. SCHIZOPHRENIA RESEARCH
- Prediction of a single psychotic episode: A 7.5-year, prospective study in first-episode psychosis
- (2010) M. Alvarez-Jimenez et al. SCHIZOPHRENIA RESEARCH
- Quality of life and subjective well-being in schizophrenia and schizophrenia spectrum disorders: Valid predictors of symptomatic response and remission?
- (2010) Rebecca Schennach-Wolff et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Identification of Novel Candidate Genes for Treatment Response to Risperidone and Susceptibility for Schizophrenia: Integrated Analysis Among Pharmacogenomics, Mouse Expression, and Genetic Case-Control Association Approaches
- (2009) Masashi Ikeda et al. BIOLOGICAL PSYCHIATRY
- The Association of Olanzapine-Induced Weight Gain with Peroxisome Proliferator–Activated Receptor-γ2 Pro12Ala Polymorphism in Patients with Schizophrenia
- (2009) Hasan Herken et al. DNA AND CELL BIOLOGY
- Genetic study of BDNF, DRD3, and their interaction in tardive dyskinesia
- (2009) Clement C. Zai et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Apolipoprotein-E gene variants associated with cardiovascular risk factors in antipsychotic recipients
- (2009) D. Clark et al. EUROPEAN PSYCHIATRY
- Early improvement as a predictor of remission and response in schizophrenia: Results from a naturalistic study
- (2009) M. Jäger et al. EUROPEAN PSYCHIATRY
- RGS4 Polymorphisms Predict Clinical Manifestations and Responses to Risperidone Treatment in Patients With Schizophrenia
- (2009) Hsien-Yuan Lane et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Association Between HTR2C and HTR2A Polymorphisms and Metabolic Abnormalities in Patients Treated With Olanzapine or Clozapine
- (2009) Arzu Gunes et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Polymorphisms of the LEP- and LEPR Gene and Obesity in Patients Using Antipsychotic Medication
- (2009) Jochem G. Gregoor et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- HTR2C Gene Polymorphisms and the Metabolic Syndrome in Patients With Schizophrenia
- (2009) Hans Mulder et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Interaction of haloperidol plasma level and antipsychotic effect in early phases of acute psychosis treatment
- (2009) Ina Giegling et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Relationship between response to risperidone, plasma concentrations of risperidone and CYP3A4 polymorphisms in schizophrenia patients
- (2009) J. Du et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Genome-wide pharmacogenomic analysis of response to treatment with antipsychotics
- (2009) J L McClay et al. MOLECULAR PSYCHIATRY
- Association analysis between functional polymorphism of the rs4606 SNP in the RGS2 gene and antipsychotic-induced Parkinsonism in Japanese patients with schizophrenia: Results from the Juntendo University Schizophrenia Projects (JUSP)
- (2009) Masayuki Higa et al. NEUROSCIENCE LETTERS
- Association between a polymorphism of the HTR3A gene and therapeutic response to risperidone treatment in drug-naive Chinese schizophrenia patients
- (2009) Bo Gu et al. Pharmacogenetics and Genomics
- The efficacies of clozapine and haloperidol in refractory schizophrenia are related to DTNBP1 variation
- (2009) Lingjun Zuo et al. Pharmacogenetics and Genomics
- Association of the α2A adrenergic receptor -1291C/G polymorphism and antipsychotic-induced weight gain in European–Americans
- (2009) Laertes Sickert et al. PHARMACOGENOMICS
- Association studies of catechol-O-methyltransferase (COMT) gene with schizophrenia and response to antipsychotic treatment
- (2009) Meenal Gupta et al. PHARMACOGENOMICS
- Association study of tardive dyskinesia and five DRD4 polymorphisms in schizophrenia patients
- (2009) C C Zai et al. PHARMACOGENOMICS JOURNAL
- A common variant in DRD3 gene is associated with risperidone-induced extrapyramidal symptoms
- (2009) P Gassó et al. PHARMACOGENOMICS JOURNAL
- ADRA1A gene is associated with BMI in chronic schizophrenia patients exposed to antipsychotics
- (2009) Y-R Liu et al. PHARMACOGENOMICS JOURNAL
- Candidate-gene association analysis of response to risperidone in African-American and white patients with schizophrenia
- (2009) B A Fijal et al. PHARMACOGENOMICS JOURNAL
- Effect of dopamine D3 receptor gene polymorphisms and clozapine treatment response: exploratory analysis of nine polymorphisms and meta-analysis of the Ser9Gly variant
- (2009) R Hwang et al. PHARMACOGENOMICS JOURNAL
- Olanzapine-induced weight gain is associated with the −759C/T and −697G/C polymorphisms of the HTR2C gene
- (2009) B R Godlewska et al. PHARMACOGENOMICS JOURNAL
- Association analysis of serotonin receptor 7 gene (HTR7) and risperidone response in Chinese schizophrenia patients
- (2009) Zhiyun Wei et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Effects of the DRD3 Ser9Gly polymorphism on aripiprazole efficacy in schizophrenic patients as modified by clinical factors
- (2009) Shih-Fen Chen et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Association study of serotonergic gene variants with antipsychotic-induced adverse reactions
- (2009) Ismail Al-Janabi et al. PSYCHIATRIC GENETICS
- Leptin Gene –2548G/A variants predict risperidone-associated weight gain in children and adolescents
- (2009) Chadi A. Calarge et al. PSYCHIATRIC GENETICS
- Association of the dopamine D3 receptor Ser9Gly and of the serotonin 2C receptor gene polymorphisms with tardive dyskinesia in Greeks with chronic schizophrenic disorder
- (2009) Emmanouil N. Rizos et al. PSYCHIATRIC GENETICS
- Genetic association of BDNF val66met and GSK-3β-50T/C polymorphisms with tardive dyskinesia
- (2009) Sung Woo Park et al. PSYCHIATRY AND CLINICAL NEUROSCIENCES
- G-protein β3 Subunit Gene 825C/T Polymorphism Is Not Associated with Olanzapine-Induced Weight Gain in Korean Schizophrenic Patients
- (2009) Young-Min Park et al. Psychiatry Investigation
- Defining “good” and “poor” outcomes in patients with schizophrenia or schizoaffective disorder: A multidimensional data-driven approach
- (2009) Ilya A. Lipkovich et al. PSYCHIATRY RESEARCH
- Lack of association between antipsychotic-induced extrapyramidal symptoms and polymorphisms in dopamine metabolism and transport genes
- (2009) Patricia Gassó et al. PSYCHIATRY RESEARCH
- Genome-wide association study of antipsychotic-induced parkinsonism severity among schizophrenia patients
- (2009) Ana Alkelai et al. PSYCHOPHARMACOLOGY
- Pharmacogenetics of parkinsonism, rigidity, rest tremor, and bradykinesia in African-Caribbean inpatients: Differences in association with dopamine and serotonin receptors
- (2008) Asmar F. Al Hadithy et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
- Acute Treatment Response and Its Predictors in Patients With First-Episode Psychosis in Iran
- (2008) Maryam Tabatabaee et al. Australasian Psychiatry
- Excess of transmission of the G allele of the -1438A/G polymorphism of the 5-HT2Areceptor gene in patients with schizophrenia responsive to antipsychotics
- (2008) Dalila Benmessaoud et al. BMC Psychiatry
- Influence of 5-HT2C receptor and leptin gene polymorphisms, smoking and drug treatment on metabolic disturbances in patients with schizophrenia
- (2008) Olga O. Yevtushenko et al. BRITISH JOURNAL OF PSYCHIATRY
- CYP2D6*3, *4, *5 AND *6 POLYMORPHISMS AND ANTIPSYCHOTIC-INDUCED EXTRAPYRAMIDAL SIDE-EFFECTS IN PATIENTS RECEIVING ANTIPSYCHOTIC THERAPY
- (2008) Anna Crescenti et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Taq1A polymorphism in the dopamine D2 receptor gene as a predictor of clinical response to aripiprazole
- (2008) Jun Soo Kwon et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Dopamine receptor D3 genotype association with greater acute positive symptom remission with olanzapine therapy in predominately caucasian patients with chronic schizophrenia or schizoaffective disorder
- (2008) David H. Adams et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Sex, Race, and Smoking Impact Olanzapine Exposure
- (2008) Kristin L. Bigos et al. JOURNAL OF CLINICAL PHARMACOLOGY
- SNAP-25 gene polymorphisms and weight gain in schizophrenic patients
- (2008) Richard Musil et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Effects of DRD2/ANKK1 gene variations and clinical factors on aripiprazole efficacy in schizophrenic patients
- (2008) Yu-Chih Shen et al. JOURNAL OF PSYCHIATRIC RESEARCH
- The role of dopamine D3, 5-HT2A and 5-HT2C receptor variants as pharmacogenetic determinants in tardive dyskinesia in African-Caribbean patients under chronic antipsychotic treatment
- (2008) B Wilffert et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The —1019 C/G polymorphism of the 5-HT1A receptor gene is associated with negative symptom response to risperidone treatment in schizophrenia patients
- (2008) L. Wang et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects?
- (2008) S Le Hellard et al. MOLECULAR PSYCHIATRY
- Association of the NPAS3 gene and five other loci with response to the antipsychotic iloperidone identified in a whole genome association study
- (2008) C Lavedan et al. MOLECULAR PSYCHIATRY
- Whole genome association study identifies polymorphisms associated with QT prolongation during iloperidone treatment of schizophrenia
- (2008) S Volpi et al. MOLECULAR PSYCHIATRY
- BDNF gene is a genetic risk factor for schizophrenia and is related to the chlorpromazine-induced extrapyramidal syndrome in the Chinese population
- (2008) Ming-Qing Xu et al. Pharmacogenetics and Genomics
- Pathway-based association analysis of genome-wide screening data suggest that genes associated with the ??-aminobutyric acid receptor signaling pathway are involved in neuroleptic-induced, treatment-resistant tardive dyskinesia
- (2008) Toshiya Inada et al. Pharmacogenetics and Genomics
- Genetic correlates of olanzapine-induced weight gain in schizophrenia subjects from north India: role of metabolic pathway genes
- (2008) Vibhuti Srivastava et al. PHARMACOGENOMICS
- G-protein gene 825C>T polymorphism is associated with response to clozapine in Brazilian schizophrenics
- (2008) Fabiana B Kohlrausch et al. PHARMACOGENOMICS
- Variants of dopamine and serotonin candidate genes as predictors of response to risperidone treatment in first-episode schizophrenia
- (2008) Masashi Ikeda et al. PHARMACOGENOMICS
- Further evidence for association of the RGS2 gene with antipsychotic-induced parkinsonism: protective role of a functional polymorphism in the 3′-untranslated region
- (2008) L Greenbaum et al. PHARMACOGENOMICS JOURNAL
- DRD4 48 bp VNTR but not 5-HT2C Cys23Ser receptor polymorphism is related to antipsychotic-induced weight gain
- (2008) J Popp et al. PHARMACOGENOMICS JOURNAL
- Predictors of the course of illness in outpatients with schizophrenia: A prospective three year study
- (2008) J.M. Haro et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- No association of serotonin transporter polymorphism (5-HTTVNTR and 5-HTTLPR) with characteristics and treatment response to atypical antipsychotic agents in schizophrenic patients
- (2008) Hwa-Young Lee et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- The influence of 5-HT2C and MDR1 genetic polymorphisms on antipsychotic-induced weight gain in female schizophrenic patients
- (2008) Martina Rojnic Kuzman et al. PSYCHIATRY RESEARCH
- Correlates of response to Olanzapine in a North Indian Schizophrenia sample
- (2008) Pramod Thomas et al. PSYCHIATRY RESEARCH
- Polymorphism of dopamine D2 receptor (TaqIA, TaqIB, and-141C Ins/Del) and dopamine degradation enzyme (COMT G158A, A-278G) genes and extrapyramidal symptoms in patients with schizophrenia and bipolar disorders
- (2008) Amalia Lafuente et al. PSYCHIATRY RESEARCH
- Pharmacogenetics in Psychiatry: Are We Ready for Widespread Clinical Use?
- (2008) M. J. Arranz et al. SCHIZOPHRENIA BULLETIN
- Amisulpride the ‘atypical’ atypical antipsychotic — Comparison to haloperidol, risperidone and clozapine
- (2008) Sridhar Natesan et al. SCHIZOPHRENIA RESEARCH
- Metabolic syndrome and insulin resistance in schizophrenia patients receiving antipsychotics genotyped for the methylenetetrahydrofolate reductase (MTHFR) 677C/T and 1298A/C variants
- (2008) Vicki L. Ellingrod et al. SCHIZOPHRENIA RESEARCH
- Pharmacogenetic study of atypical antipsychotic drug response: Involvement of the norepinephrine transporter gene
- (2007) A. Méary et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
- The CNR1 gene as a pharmacogenetic factor for antipsychotics rather than a susceptibility gene for schizophrenia
- (2007) Nora Hamdani et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- An investigation of theα1A-adrenergic receptor gene and antipsychotic-induced side-effects
- (2007) Pilar A. Saiz et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Possible association between the −2548A/G polymorphism of the leptin gene and olanzapine-induced weight gain
- (2007) Seung-Gul Kang et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Associations between MDR1 gene polymorphisms and schizophrenia and therapeutic response to olanzapine in female schizophrenic patients
- (2006) Nada Bozina et al. JOURNAL OF PSYCHIATRIC RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now